advanced search

Welcome: Guest

log in

Antithrombotics Market Forecast

Publication Date January 2009
Publisher Datamonitor
Product Type Interactive Model
Pages
ISBN Number not applicable
Product Code DAT14422
Buy this product or for assistance call +44 20 7060 7474

Summary

Introduction
The antithrombotic market is expected to grow to $22 billion by 2017. The growth will mainly be due to the introduction of new agents onto the market, such as prasugrel and rivaroxaban, which will offer significant improvements over the current standards of care (Plavix (clopidogrel) and warfarin, respectively).

Scope



Highlights



Reasons to Purchase


  • Quantify the future size and understand the background of the antithrombotics market
  • Understand the commercial landscape in terms of new product potential
  • Understand the barriers to uptake for novel antithrombotics.
  • Content

    • Please note that this product is delivered as an interactive model. The model is an Excel document and its data can be manipulated and used as per your needs. The data when extracted and used must be correctly cited to the publisher. This product does not include numbers of pages due to the format that it is supplied in. Should you have any queries regarding the model or would like a demo please do not hesitate to call us on Tel: +44 (0) 20 7060 7474 or email our customer service on service@reportbuyer.com
    Delivery Details

    PDF:Delivered by email usually within 4 to 8 UK business hours.

    Industry Events

    Orphan & Ultra Orphan Drugs

    13 Jan 10 to 14 Jan 10
    Brussels, Belgium
    view summary >>

    Oncology Market & Patient Access

    14 Dec 09 to 16 Dec 09
    Prague, Czech Republic
    view summary >>